Indications and Purposes
| 1 Indications And Usage Korlym (Mifepristone) Is A Cortisol Receptor Blocker Indicated To Control Hyperglycemia Secondary To Hypercortisolism In Adult Patients With Endogenous Cushing's Syndrome Who Have Type 2 Diabetes Mellitus Or Glucose Intolerance And Have Failed Surgery Or Are Not Candidates For Surgery. Limitations Of Use: Korlym Should Not Be Used In The Treatment Of Patients With Type 2 Diabetes Unless It Is Secondary To Cushing's Syndrome. Korlym (Mifepristone) Is A Cortisol Receptor Blocker Indicated To Control Hyperglycemia Secondary To Hypercortisolism In Adult Patients With Endogenous Cushing's Syndrome Who Have Type 2 Diabetes Mellitus Or Glucose Intolerance And Have Failed Surgery Or Are Not Candidates For Surgery ( 1 ). Important Limitations Of Use: Do Not Use For The Treatment Of Type 2 Diabetes Mellitus Unrelated To Endogenous Cushing's Syndrome. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Mifepristone |